pfizer shares are doing really well. of course pfizer shares have already done really well.his could really change the course of the economic recovery. amanda: what it says about pfizer, morningstar saying they're not changing the fair value because the long tail is not there. but pfizer's ability of bringing this is very meaningful. that may be why we are seeing companies like moderna suffering. this speaks to pfizer's ability to turn its pipeline into reality. matt: might interesting take on this is that it does give anti-vaxers more traction, especially those against vaccine mandates, because why would you mandate a vaccine if there is a treatment that cures you from the disease anyway as soon as you get it. joining us to talk about is our number -- our bloomberg health reporter. what do we know about this. clinical trial stopped because they were so successful. should we believe this really works? robert: what we have is a statement from the company. there is no scientific study published. so we don't know the details yet, just the top line data but pfizer has been relia

specifically, the pfizer vaccine. so the bottom line is there's plenty of supply of pfizer vaccine and we look forward to parents having the opportunity to vaccinate their kids. thank you for today's briefing and we look forward to seeing everybody later in the week. thank you.

pfizer, jim, pfizer, pfizer pills, 89% pretty good news >> well, dr.d i'm thinking, oh my god, there it is, he just said the end of the pandemic. here's a man that's gotten it right all the way as you said you have to say the pfizer stuff. but, yeah, i mean, i think we have to just recognize that this is the anti-teleton pro-lifetime fitness world. i just think this was -- did anyone hear that he said that the pandemic was over? like they're talking about employment i don't care about the employment the pandemic ended >> he tweeted that out that he said that. what is the rate 4, it's fought a forehand him this is theoretically before the pandemic end, it was the october numbers. so this could be good for stocks >> it's good you know, there are people, joe, who come on all day and they find something that they think is bad okay well, sometimes things are good and this is one of those times i think we could sit here and say, well, but wait a second if you look at you look at the wages, forget it today is a good day. the only people unhappy are people who

specifically the pfizer vaccine. the bottom line is there is plenty of supply of the pfizer vaccine and we look forward to parents having the opportunity to vaccinate their kids. thank you for today's briefing and we look forward to seeing everybody later in the week. thank you. >> in a couple of moments, the house will be logging in and they will be dabbling in for speeches with legislative work coming at 2:00 p.m. members

specifically, the pfizer vaccine. so the bottom line is there's plenty of supply of pfizer vaccine and we look forward to parents having the opportunity to vaccinate their kids. thank you for today's briefing and we look forward to seeing everybody later in the week. thank you. snoot [captions copyright national cable satellite corp. 2021] national captioning institute, which is responsible for its caption content and accuracy. visit ncicap.org] >> the house returns at 6:30 p.m. eastern to vote on several native american lands and casino bills, marking the beginning of native american heritage month. when the house returns, watch live coverage here on c-span. ♪ ♪ >> c-span's "washington journal" every day we are taking your calls live on the air, on the news of the day. we'll discuss policy issues that impact you. coming up tuesday morning, we'll discuss the latest on president biden's build back better agenda. with south carolina republican congresswoman nancy mace. and wisconsin democratic congressman, mark pocan. e

pfizer vaccine be offered it second dose _ pfizer vaccine be offered it second dose of _ pfizer vaccine high level— reminder the first vaccine dose gives a high level protection i gives a high level protection against _ gives a high level protection against serious _ gives a high level protection against serious disease - gives a high level protection against serious disease and | gives a high level protection - against serious disease and that hi-h against serious disease and that high level— against serious disease and that high level protection _ against serious disease and that high level protection we - against serious disease and that high level protection we know . against serious disease and that. high level protection we know lasts for at _ high level protection we know lasts for at least — high level protection we know lasts for at least 12 — high level protection we know lasts for at least 12 to _ high level protection we know lasts for at least 12 to 16 _ high level protection we know lasts for at least 12 to 16 weeks. - high level protection we know lasts for at least 12 to

between pfizer and moderna there still a group that are not eligible yet for the booster shot.ed on those that want to get the booster shot are not as well protected as those who are. so what is the message sheer people and is it likely everyone can get a booster soon? >> the short answer is yes. it will be likely everyone can get a booster within a period of time. i want people to appreciate looking at the pace and the cadence of vaccinations in the united states but it is still quite protected against severe disease and hospitalization. to so to show the data from israel biden due to we will have equity that was in a booster situation as needed. >> over the overwhelming number of new infections are from those were not vaccinated? >> . >> . >> and with that vaccine. lessons and young children also said it was delaying the l emergency use authorization request for kids ages six through 11 years of age. how do these developments affect the rollout with the administration is fairly confident that pfizer can supply an adequate number of those doses. so can they get enough to outst

pfizer up 9% merck down about the sam amount. seeing regeneron down almost 6% and moderna down almost 20%. that's less than earlier tough week for moderna in general. guys >> you know who's having a tough day is emergent bio solutions, more drama with the contract manufacturer of the covid-19 vaccines what's behind the move >> yeah. they announced last night that they had ended a contract with the u.s. government that essentially had reserve space to manufacture covid vaccine. they were making two in the same plant and cross contamination and stopped macking the astrazeneca vaccine and doesn't affect the partnership with j&j and working for clearance for that plant and the doses out there but down 42% on this guys >> thank you so much. >>> let's bring in jared holtz to continue the conversation how positive for pfizer and for the nation as a whole, the world, is this pfizer data >> hey, wilf, thank you for having me. the impact on the world is very, very significant one of the better days we have seen just from a broader perspect

pfizer chairman and ceo, albert bourla.ur thanks to david westin for that interview with albert bourla. pfizer stock on the move today. we are keeping our eyes on that. for matt miller, i'm amanda lang. this is bloomberg. ♪ >> advisors to the centers for disease control and prevention are meeting today to discuss giving the pfizer biontech coronavirus vaccine to children ages five to 11 years old. they are expected to recommend moving forward. the food and drug administration has already authorized the two shot regimen. the biden administration says it has enough of the pfizer biontech vaccine for all 28 million children in this age group. today's election for governor of virginia offered the clearest picture yet of how much momentum republicans will have in the 2022 vote for congress. gop candidate -- one gop candidate is backed by donald trump. the second candidate is betting the president's legacy will turn out echo credit voters -- turnout democratic voters. the belgian prime minister said europe was leading the way on

. >>> right now and streaming on cbsn, a bear, a major announcement from pfizer. the promising new bill uld be a game changer for coronavirus. >>> parents, your kids could get the covid shot. i'm justin andrews with a live report. >> and. >> the arrest just made. >> and getting to and from san francisco's ferry boating could soon cost you more. the proposal on on the table this morning. good morning, rid is friday, november 5th . >>> and we have a lot to lookr. and let's look at wealther and traffic your friday forecast. >> and has a ring to it. >>> we are looking at beautiful weather ahead. mild conditions as we go through our day today. it is a chilly one first thing. so grab that jacket as you head out the door. we are several degrees colder compared to yesterday at this time. as we go through our day today, along the coast, upper 50s. we're going to see more clouds stream in. low to mid 60s around tuberculosis bay and mid to upper 60s inland. some clouds rolling in here. we'll talk more about that weekend forecast and seven-day forecast in a few minutes. a lit

, a whistleblower report in the british medical journal points to serious flaws in the testing of pfizer scope of vaccine. although so far us authorities have been reluctant to investigate them and caught canada's top court backs a comedian who made a series of controversial jokes about a disabled singer stating that it didn't amount to discrimination. we put the issue up for debate, the must be a stop between hatred and comedy, between violence and free speech, no one saying there shouldn't be consequences. what the argument is, the consequence should not be. you mean by tens of thousands of dollars and not be alive, centrally, not allowed to criticize someone. ah, it's 3. i'm here on the russian capital and you're watching r t international. my name is donald quarter. welcome to the program. the rec interior ministry has condemned to what it's called a terrorist attack against the prime minister. early on sunday, mustafah academies residence in the capital of baghdad was bombed by drones. although the premier was left unharmed, ortiz policy or picks up the story. i'm in a similar a ska

dates of interview generated for the pfizer trial. it's a crazy mess. those are some pretty serious concerns, but let me give you the full picture. these were comments that the journal received anonymously from former employees of one of the firm's tasks with carrying out the pfizer vaccine trial. van ta via the authors got in touch with them while investigating the claims of a whistleblower who had worked for ven tabio for a couple of weeks before being fired. supposedly in connection with sounding the alarm over quite a list of issues including things like this. the, the, the, the, the whistleblower provided the journal with internal company documents, photos, and audio recordings to back up her concerns. i do have to say though, we've not seen them in the article or received actually some other way. and obviously it wasn't up to us to supervise an american contract or on a pivotal trial of one of the world's most widely known jobs. the question is, did the u. s. government agency in charge the food and drug administration know abou

pfizer officially requesting the fda authorize booster shots for all adults 18 and older. they say the data shows the third covid shot, the booster, offering 95% protection against symptomatic infections regardless of age. how soon could this happen? >>> also on vaccinations tonight, news this evening involving nfl star aaron rodgers facing backlash after saying months ago he was immunized. tonight, he says he takes full responsibility for comments that he says some might have felt were misleading. tonight, one big sports name not having it. >>> chilling new images of the deadly chaos at that concert in houston. screaming fans trapped. tonight, what the fire chief is now saying. >>> also tonight, new drone video revealed for the first time at the kyle rittenhouse trial in kenosha, wisconsin. what prosecutors say it shows. what the medical naexaminer sai in court today about the gunshot and what it could show. and what the m.e. said when pressed by the defense. >>> news tonight in the january 6th investigation. that select committee with ten new subpoenas, closing in on for

a, they've got full confidence in the pfizer vaccine, which is great. it's not a problem with a vaccine. it works, it's fine, it's safe, it's the procedure, isn't it? and that a whistleblower potentially wasn't listen to. that's a concern in terms of keeping public trust in order calling because do you think you think you're quite right? this is all relates to revelations in the, in the medical journal, as you say, not from yesterday. and as you say, this book, jackson was a senior employee the over this contract fi, there was a big enough company conducting sites, trials across from 153 sites across the world, many of them sub contract it out commercially practice, which is very common when within the american medical establishment, and this relates to just that he say 3 of those type and a 1000 to the patient. but the revelation really quite darkling, including, as you say, essentially the fact that the entire chrome may have been non blinded. so it was apparent to staff whether patients were receiving the placebo or, or the actual vaccine. real safet

pfizer announcing its own new covid pill. they say it's taken within days of getting symptoms and pfizer says it cuts down the risk of hospitalization or death by nearly 90%. we also have important news tonight for parents who want to get their children vaccinated this weekend. here's whit johnson. >> reporter: tonight, a potential new weapon in the fight against covid. vaccine maker pfizer announcing early trial results of its an the i viral pill show it cut the risk of hospitalization or death by 89%. >> it's really exciting to know that there might be an option to provide patients that could help save their life. >> reporter: the drug called paxlovid was given to high risk patients within three days of developing covid symptoms. it comes just a month after merck reported its new antiviral drug cut the risk of hospitalization or death in half. >> while the news around these pills is incredibly exciting, this does not in any way replace the need for vaccination. the vaccines still represent our safest and most effective way

pfizer shares up 8%. its rivals are seeking merck, which has a similar treatment down almost 9% moderna down 8%. now, will markets continue going to all-time highs? some stocks are making unusually outsized moves sometimes catalysts are there. but the spikes are unprecedented. avis up 70% this week, spiking 100% after results bed bath and beyond pacing for 50% this week after a partnership with kroger and nvidia and tesla also up double digits this week with such volatile moves how much is increased options activities playing into the price action are they telling us anything about where the spikes could be coming next. joining me now, chris murphy of susquehanna. have things changed in options land. >> you nailed it huge spikes in the stock prices for the stocks you named we are also seeing a huge spike in implied volatility levels for those stocks and a huge spike in call volume. that is the classic meme, slash, message board stock we have been talking about for a while. teslais up a ton implied volatil

and global distribution of the pfizer-biontech vaccine.it is my honor to host this discussion. before he receives his award tomorrow evening at the andrew mellon auditorium in washington, d.c., at an event that mark -- that marks the atlantic council's 60th anniversary. we are joined on this platform by dr. bourla's partners in creating this extraordinary vaccine, the cofounders of the german company, biontech. together, pfizer and biontech achieved one of the great scientific breakthroughs in history, with its groundbreaking messenger mrna vaccine. messenger are -- rna technology. it is hard to imagine a more dramatic transatlantic success story than this one. born of a science and partnership that predated the pandemic we will get to that in a moment. but first, dr. borla, i welcome you to atlantic council from page. >> thank you very much. >> you are a greek born american. you called yourself greek i birth and american by choice. son of holocaust survivors from greece. as i understand it there were 50,000 greek jews before world war ii

you are on the pfizer board pfizer announced today something concerning children that i want to go back to the development of the vaccine. they want to know what moderna seems to be better than pfizer? [laughter] >> pfizer put outdated today from phase two, phase three ages five to 11 shows the immune response measured by the antibiotic production and five -- 11 years old was comparable to ages 16 to 25 reserved 8:30 microgram dose. it's 30 micrograms the process being developed for children between the ages of fivee and 11, the reason pfizer chose you want the lowest dose possible that's going to achieve antibody response this dose looks like it's a comparable immune response of the adult dose but at a much lower dose. you'll get presumably you will get less vaccine side effects, less fevers, less arm pain, and a young child you want a vaccine that's a very safe, highly tolerable. that was the effort to test multiple doses to arrive at the 10-microgram dose. pfizer has the data from the trailpf it was conducted in 90 trial sites. weeks not months i typically meant four -- six weeks if

pfizer on this very encouraging news. this is the end of the pandemic as we know what, up about 7.5%. at one point, up 13%. at that point, the best day ever for pfizer. we also have the russell 2000, that reopening trade outperforming. it is interesting because the nasdaq, which has grown, it is underperforming a little bit. but still up 0.5% and up for a 10th day in a row. the eighth record closing high in a row. what we are looking in white is a nasdaq 100, the longest running streak of the year since last year. below, we are looking at the 10 year yield. as yields go down, that makes the valuation look more attractive. it also makes assets more valuable as discount rates, in. that is the dynamic that we have seen this year. we are certainly seeing it right now. as we take a look at it from a correlation standpoint, we are going to see not surprisingly that as yields have come in so quickly, the correlation between yields and stocks coming down, that has been the story. when it has been positive, that has been in volati

sx3 and y. >>> booming vaccine demand boosting pfizer's bottom line. and a cash back deal to take care of your next holiday meal. kpix5 anchor len kiese has the money watch report. >> reporter: a boost for pfizer. the drug maker says it is on track to deliver more than 2 billion shots of its coronavirus vaccine this year. it earned $7.7 billion in its third quarter and ranked in $24 billion in revenue. vaccine sales made up more than 60% of the number. >>> clorox says it earned $142 million. >>> another retailer is getting an early start. target is releasing discounted items. beats headphones slashed to less than $100. they cut the price of one hp laptop and lol surprise dolls for the little girl on your list. >>> and a thanksgiving feast with no financial fuss. ibada is bringing back its free holiday spread this year. the cash back app is collaborating with wal-mart to offer 100% cash back on 10 thanksgiving staples. this includes stuffing mix, gravy, mashed potatoes, and the cost of a turkey up to $15. customers have to purchase the products first an

the breaking news: pfizer asked the f.d.a.thorize its booster for even more americans as kids wait in long lines for their first shots. investigating the horror in houston: after that deadly concert, narcotics and homicide detectives try to figure out how this could happen as we learn who had the authority to stop the show. plus, a nine-year-old still in a medically indduceded coma fightg fofor his life. with thanksgiving just weeks away, could sky-high gas pricess and understaffefed airportsts ld to a a travel ni

rochelle walensky has given the go ahead for pfizer anticipated -- pfizer's pediatric vaccine in children 5 to 11. a panel voted late tuesday to recommend use of the low-dose shot. >> the clinical trial demonstrated that the pfizer/biontech covid-19 is safe, immunogenic, and efficacious in children 5 through 11. >> reporter: more than 67,000 american children under age 17 have been hospitalized for covid infections since august of 2020. while the cdc says the most severe covid outcomes are rare, there have been 94 deaths in kids 5 to 11. >> the risk is too high and too devastating to our children, and far higher than for many other diseases for which we vaccinate children. >> reporter: some parents say access to a pediatric vaccine will lift a heavy burden. >> it will make life that much easier to be able to take the kids places, to not feel so worried about do we have a mask, do we not have a mask, can we be aroundthese friends and their kids. >> reporter: a survey shows only 27% of parents say they'll vaccine their kids right away. a third says they'll see how it goes. >> i recognize th

and the news on that new covid pill, pfizer requesting the fda authorize the pill that pfizer says is 89% effective at preventing hospitalization and death. and big news tonight on new year's eve in times square. here's abc's stephanie ramos. >> reporter: tonight, we're learning the fda is planning to authorize pfizer booster shots for all adults on friday. a cdc panel is scheduled to meet at the end of the week, with a new wave of vaccines going into arms as soon as this weekend, to slow a winter surge. a growing number of states have already gotten ahead of cdc guidelines and made boosters available to all adults. but even if those states, some people say, the mixed messages haven't made it easy to book a shot. >> they're like, "yeah, we don't care what santa clara county says, we only care what the cdc says." i'm not going to lie. i'm a very honest person. >> reporter: some health experts say the patchwork booster rollout isn't working. >> frankly, the fda and cdc have made a major strategic mistake. they have made the booster guidance so confusing that people don't know who should

covid-19 vaccine maker pfizer. it's now asking the fda to grant emergency use authorization for paxlovid a pill doctors could prescribe to treat those infected with covid-19 your healthcare professional calling prescriptions at walgreens. you go to walgreens, you pick up 5 pack. >> course and you start taking it lo and behold, it prevents you from going to the hospital. biser's says its studies show high-risk unvaccinated volunteers who started taking the pills. >> within 3 days of getting symptoms greatly reduce their risk of severe disease and death. here's a way that we could tolerate counting a certain amount of transmission going on. >> but not squeezing the hospitals in the hospital for space infectious disease. experts say these pills provide yet another tool in the tool box in the fight against covid-19 people who have been hesitant to get vaccine. and who get infected might not be as tend to get drugs. and this may be a a different approach for certain parts of the country >> vaccination coverages is much

there's been no response from pfizer. from that company or from the f t a you surprised we didn't get a quicker response yet. it's always good to respond because then it's cautious the story. and here i am responding saying, look, ah, there may have been an issue. i don't know. we don't know. on the other hand, the important message is i have to convey is the pfizer vaccine works. it works very well, and it is safe. and, and the advisor chairman and chief executive albert burleigh said they're working at the speed of science as quickly as they possibly could. what would you like pfizer to do here? now, as you said, this is a very small sample of very small case. it's just have a very small part of the testing. but would you like to see them do something public? well, actually, it's good for all are a such vaccine manufacturers astrazeneca mcdonough? sputnik, pfizer, et cetera, to do due diligence with whom they sub contract, the sub testing to it is always important to do the due diligence and random checks that they're d

on the contrary, the watchdog was instead quick to greenlight, pfizer for emergency use in america. in 5 as briefing document submitted, sta advisory committee meeting held on the 10th of december 2020. the company made no mention of problems of the events of your sites. the next day, the issue, the emergency use authorization of the vaccine. a few more details that mike disconcert, a summary of f, the a inspections of pfizer vaccine trial sites said that 9 of 153 had been inspected. but none of those had been operated by vent avia and no expection had been conducted at all in the 8 months between the emergency authorise zation and the full approval. pfizer has since hired been toby up as a research subcontractor to work on for other clinical trials, the use of the coven vaccine, and children, and young adults, a cobit 19 trial involving pregnant woman and a trial of cobit 19 booster doses. this is a global pandemic, and in a global pandemic, we have a duty. this is the important bass. we have a duty, we have an up must duty to after other nations. it is a clear example of we look a

merck has one of these antiviral pills, pfizer has one of them, too. the merck clinical results looked really good in terms of people being kept alive, getting out of the hospital if they could get that drug soon after being diagnosed with covid. the merck results were good, but the pfizer clinical trial results looked even better. the pfizer clinical trial results showed nearly 90% efficacy at keeping people out of the hospital and alive if they could get this drug, this new pfizer antiviral drug, again, that you take as a pill soon after contracting covid. again, pfizer has just put in to the fda to have that treatment authorized for use in the united states. merck's application for its antiviral treatment is already being processed at the fda. that's all good, having a whole new armamentarium of clinically proven effective drugs to treat covid. that is a big deal, a really big advance in terms of the fight against this pandemic. we also have monoclonal antibodies, and if you can get those monoclonal antibodies in time to people, they, too, show effe

pfizer's vaccine for -11-year-olds just got approved. i want to start with why cdc's definition of community transmission negatively impacting us? >> them away community transmission was defined before vaccinations made sense -- based on two parameters -- test positivity, which you can lower if you tested a lot, places like san francisco test a lot. and then, the number of cases over 100,000 people. in the case of mask systematic testing, which we did to see if we could break chains of transmission, so we could test anyone who didn't feel well, come and test. there were a lot of testing sites. that meant we would really be able to catch people with cases and know how many cases are in the community. the cdc after vaccination is don't go in test unless you have had an exposure or don't feel well. so if you do not go and test, you are likely to have covid. so cases over 100,000 people are going to be high because we are testing the way the cdc tells us to test, which is go and test if you have been exposed to covid. it doesn't tell you the

a drug that pfizer says. covid-19 hospitalization and death.ils coming up. >>> a closer look at how it is affecting the bottom line. >> the state is on capitol hill. the vote expected on commander in chief's big social reform plan. >> what we just learned about the state of the economy with the release of the october jobs report. it is friday, november 5th. we're going to start with a look at wealther and traffic. good morning to you guys. happy friday. >> we are looking forward to a nice weekend. >> a beautiful day today. it is a dry mild conditions. as we look to our weekend getting ready for that. most of us will be dry. we'll talk about this in just a moment. we need the rain. that is coming next week. for today, we are looking at our treasure island camera. it is a chillier start to our day. bundle up as we head out the door. as we head through the afternoon, we're going to see some clouds come in. a mix of sun and clouds. temperatures a little bit cooler compared to yesterday and below average. upper 50s along the coast. looking at low to

why do you need pfizer's help? david is crushed in the goliath that is ab vieh. >> we are the number one subscribed -- here in the united states and nur tech otc with the action and dual acting prevention effects could prevent the next attack is differentiating from abbvie and what you look at what we've done here, we want to bring the same profile to patients in the outside of the u.s. and if a small company like ourself tried to do that around the globe, the infrastructure spending cash burn would not let us goat to profitability unless you have multiple drugs in your pipeline, it is very difficult to bring drugs and commercialize it across the globe pfizer has those capabilities, that is a big brand presence in every market across the world and they're going to team up with us and help us continue to be the market leaders across the globe. >> so doctor, i want to amazon before i came out here and oh, look at this we have tylenol, ultra relief extra strength for $8. we've got the excedrin, i took about a thousand

your children will get the kids version of the pfizer vaccine. doctors say they will get two doses roughly three weeks apart for maximum protection. other health care providers are also stocking up and will be able to give shots to kids very soon. the county's health officer said that they have lost too many kids to the virus and said it's preventable with this vaccine. >> kids are driving the epidemic right now and getting them vaccinated, getting them protected is really important. we see that kids, most the time do well but some kids do get really sick with coronavirus. 30% of kids get in the hospital with coronavirus have no underlying medical conditions. they are healthy kids and still get really sick. >> and the vaccine should be available for kids younger than five during the early months of next year. in contra costa. justin andrews. >>> tomorrow san mateo county opens it's first clinic for those ages five to 11. it has a play land theme. it runs from nine to 4:00 p.m. tomorrow and next saturday. then 2:30 to 7:00 p.m. next wednesday thro

at this rose to 93% two weeks after having a pfizer boosterjab. for those pfizer booster jab.zer boosterjab. for those who had two doses of pfizer, their protection ro5e who had two doses of pfizer, their protection rose from 63% to 9a%. what is unclear i5 their protection rose from 63% to 9a%. what is unclear is how long this huge boost in protection will last. if long this huge boost in protection will last. if the brewster _ protection will last. if the brewster programme - protection will last. if the brewster programme is l brewster programme is successful, and with very high uptake, we can ma55ively reduced the worry about hospitalisation and death due to covid a christmas and for the rest of this winter for literally millions of people —— boo5ter. if: literally millions of people -- booster. ' ~ ., ' literally millions of people -- booster. ' ~ . ' , ., ., , booster. 16 and 17 -year-olds will now be — booster. 16 and 17 -year-olds will now be offered _ booster. 16 and 17 -year-olds will now be offered a - booster. 16 and 17 -year-olds will now be offered a second | will

you're on the pfizer board. pfizer announced today something concerning children. can you just describe what happened today and i want to go back to the development of the vaccine and i want you to also some people in the crowd want to know why motor appears to be better than pfizer. >> so pfizer put data today from a phase 2 trial on the vaccine in development for children ages 5 to 11 and the data was positive. it should be immune response measured by the anti-money production of the vaccine induces is comparable to the anti-body response in children ages 16 to 25 who receive the 30 microgram dose so it goes in adults and children over the age of 12 is the micrograms. the dose being developed for children between ages of five and 11 is a 10 milligrams dose and the reason pfizer chose that does is there were multiple doses tested and what you want to try to achieve is the lowest dose possible that's going to achieve anti-body response for an immune response is going tobe effective . this does looks like it achieve a comparable immune response to the adult dose wit

the breaking news: pfizer asked the f.d.a. to authorize its booster for even more americans as kids wait in long lines for their first shots. investigating the horror in houston: after that deadly concert, narcotics and homicide detectives try to figure out how this could happen as we learn who had the authority to stop the show. plus, a nine-year-old still in a medically induced coma fighting for his life. with thanksgiving just weeks away, could sky-high gas prices and understaffed airports lead to a travel nightmare for americans hitting the road? violent threat: the sad state of politics as a republican congressman and his family is threatened with death for voting in favor of a bipartisan infrastructure bill. >> i hope you die. i hope everybody in your (bleep) family dies. >> o'donnell: our series "honoring our heroes," meet the family of this decorated navy seal who died by suicide. the new way they're trying to help veterans in need. an ideal bedtime? more evidence a good night's sleep is essential to good health. what